Stacey Rd is a highly-accomplished National Account Director at Gilead Sciences, where she leverages her extensive expertise in pharmaceutical management to drive strategic initiatives across high-volume, complex national accounts. With a proven track record of success in account management, Stacey is adept at developing and...
Stacey Rd is a highly-accomplished National Account Director at Gilead Sciences, where she leverages her extensive expertise in pharmaceutical management to drive strategic initiatives across high-volume, complex national accounts. With a proven track record of success in account management, Stacey is adept at developing and implementing competitive account strategies that secure access for Gilead and Asegua portfolio products. Her focus spans various sectors, including commercial, Health Insurance Exchanges (HIX), managed Medicaid, and Medicare Part D plans, ensuring that Gilead’s innovative therapies reach the patients who need them most.
Stacey’s role is pivotal in fostering long-term relationships with executives at key customer organizations, which is essential for generating customer loyalty and enhancing market share. Her reputation for building trusted partnerships is complemented by her exceptional skills in contract negotiation and account planning, allowing her to navigate the complexities of the pharmaceutical landscape effectively.
Currently, Stacey is spearheading several key projects aimed at expanding Gilead's footprint in therapeutic areas such as viral hepatitis, HIV, cardiology, and rheumatoid arthritis. By actively cultivating a robust network within account organizations, she not only enhances Gilead's visibility but also positions the company as a leader in delivering innovative healthcare solutions. Her strong presentation skills and strategic mindset enable her to communicate effectively with stakeholders, ensuring alignment on objectives and driving successful outcomes for both Gilead and its partners. Through her leadership, Stacey continues to make significant contributions to the advancement of public health and the pharmaceutical industry.
